Importance of pharmaceutical care in compounding drug as a professional pharmaceutical service
DOI:
https://doi.org/10.60103/phc.v27.e875Keywords:
compounding drug; dispensing; pharmaceutical careAbstract
Introduction: Community pharmacy must guarantee a suitable professional compounding drug dispensing service in which two phases are differentiated. Phase one involves assessing the prescription, collecting the necessary data to guarantee safety and effectiveness of the preparation and selecting the appropriate excipient. Phase two involves handing the preparation to the patient with oral and written information in order to guarantee correct identification, conservation and use.
Objectives: Analyze necessary data collected when the prescription for a compounding drug is received and to what extent the patient is informed about correct conservation and use. Assess the results obtained, in order to determine corrective actions and improvement opportunities in the dispensing process of individualized medication.
Method: Observational cross-sectional observational study was carried out by means of a 10-item questionnaire sent to the community pharmacists of Bizkaia to analyze actions in the two phases of dispensing and manufacturing requests to third parties.
Results: 91.9% ask for whom the medication is for, 6.1 % never ask about the illness, and 12.4% never ask about dosage. 91.4% always hand the patient information leaflet and 5.2 % never perform oral reinforcement.
Conclusions: Most community pharmacists in Bizkaia perform a good professional practice in both phases of compounding drug dispensing process, but there is great room for improvement, mainly regarding information about the disease to be treated and its localization, as well as in oral reinforcement when handing over the compounding drug. The training interventions carried out to date have improved professional practice, but further actions are needed to optimize the dispensing of individualized drug.
Downloads
References
Foro de Atención Farmacéutica-farmacia Comunitaria (Foro AF-FC), panel de expertos. Guía práctica para los Servicios Profesionales Farmacéuticos Asistenciales desde la Farmacia Comunitaria. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2024.
Pacho L, Hidalgo ME, Sanz S, Echeverria L, Arco del J. Procedimiento de recepción y entrega de fórmulas magistrales a los pacientes. P-07-21. Argibideak. 32(1). Enero –Febrero 2022.
REAL DECRETO 175/2001, de 23 de febrero, por el que se aprueban las normas de correcta elaboración y control de calidad de fórmulas magistrales y preparados oficinales (B.O.E. nº 65-16/03/01).Disponible en: https://boe.es/buscar/pdf/2001/BOE-A-2001-5185-consolidado.pdf
Pacho L, Arechabaleta E, Hidalgo ME. Valoración de la importancia de la comunicación con el paciente para elaborar correctamente fórmulas magistrales. Pharm Care Esp. 2024; 26 “suppl.” Disponible en: https://pharmcareesp.com/index.php/PharmaCARE/article/view/843/799
Heitman T, Day AJ, Bassani AS. Pediatric Compounding Pharmacy: Taking on the Responsibility of Providing Quality Customized Prescriptions. Children (Basel). 2019; 6(5):66. doi:10.3390/children6050066.
Hidalgo ME, Pacho L. Intervenciones para optimizar la dispensación de fórmulas magistrales. En: 22º Congreso Nacional Farmacéutico. Sevilla: Consejo General de Colegios Farmacéuticos de España; 2022.
Hidalgo ME, Pacho L. Procedures to optimise the dispense of compounding medications. En: 80º Congreso Mundial de Farmacia. Sevilla: Federación Farmacéutica internacional (FIP); 2022.
Alcalá PJ, Domingo A, Salmerón MJ, Casado C, Díaz P, Hernández ÁA, Rodríguez B; en representación del Comité de Calidad Asistencial y Seguridad del Paciente de la Asociación Española de Pediatría. Safe handoff practices and improvement of communication in different paediatric settings. An Pediatr (Engl Ed). 2023; 99(3):185-94. doi: 10.1016/j.anpede.2023.08.008.
Carvaho M, Almeida IF. The Role of Pharmaceutical Compounding in Promoting Medication Adherence. Pharmaceuticals. 2022; 15(9):1091. doi:10.3390/ph15091091.
Donna M. Lisi, Pharm D, BCPS, BCGP, BCPP, BCACP. Pros and Cons of Pharmacy Compounding. U.S. Pharmacist. Pediatrics. 2021. [Internet]. [Consultado 11 noviembre 2024]. Disponible en: https://www.uspharmacist.com/article/pros-and-cons-of-pharmacy-compounding
Herledan C, Cerfon MA, Baudouin A, Larbre V, Lattard C, Poletto N, Ranchon F, Rioufol C. Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review. J Geriatr Oncol. 2023; 14(4):101450. doi:10.1016/j.jgo.2023.101450.
Isnenia, Siti Julaiha. Mother’s Knowledge of Expiration Dates, Beyond-Use Date (BUD), and Storage Conditions for Compounding and Non-Compounding Drugs. [Internet]. [Consultado 11 noviembre 2024]. Disponible en: https://jkefarind.com/index.php/jki/article/view/6634
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Miren Edurne Hidalgo Pérez, Leire Pacho Merino
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
